Cancer Therapeutics CRC is a small molecule drug discovery company that is translating innovative cancer biology research into lead and preclinical stage drug candidates. In particular it is targeting novel cancer pathways associated with the tumour microenvironment or growth, to develop novel treatments for breast, prostate, melanoma, lung and brain cancers. Read more...
Cancer Therapeutics CRC has a pipeline of innovative early stage small molecule oncology programs, backed up with data-rich packages, which are available for partnering or out-licensing. Read more...